Cargando…
Recent Antifungal Pipeline Developments against Candida auris: A Systematic Review
The alarming spread and impact of multidrug-resistant Candida auris infections alongside the limited therapeutic options have prompted the development of new antifungals. These promising agents are currently in different stages of development, offering novel dosing regimens and mechanisms of action....
Autores principales: | Treviño-Rangel, Rogelio de J., González, Gloria M., Montoya, Alexandra M., Rojas, Olga C., Elizondo-Zertuche, Mariana, Álvarez-Villalobos, Neri A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695453/ https://www.ncbi.nlm.nih.gov/pubmed/36354911 http://dx.doi.org/10.3390/jof8111144 |
Ejemplares similares
-
Evaluation of the synergistic antifungal activity of micafungin and voriconazole plus sertraline against Candida auris
por: Alanís-Ríos, Sergio A., et al.
Publicado: (2022) -
Outbreak of Candida auris infection in a COVID-19 hospital in Mexico
por: Villanueva-Lozano, Hiram, et al.
Publicado: (2021) -
Antifungal Resistance in Candida auris: Molecular Determinants
por: Frías-De-León, María Guadalupe, et al.
Publicado: (2020) -
Identification and Elimination of Antifungal Tolerance in Candida auris
por: Rasouli Koohi, Samira, et al.
Publicado: (2023) -
Candida auris: Epidemiology, biology, antifungal resistance, and virulence
por: Du, Han, et al.
Publicado: (2020)